Gene · 3587
Papers3,503
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 3,503
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA methylation of ARHGAP30 is negatively associated with ARHGAP30 expression in lung adenocarcinoma, which reduces tumor immunity and is detrimental to patient survival. | Aging (Albany NY) | 2021 | 34910688 | PubTator, text mining | PubMed |
| Autosomal recessive 333 base pair interleukin 10 receptor alpha subunit deletion in very early-onset inflammatory bowel disease. | World J Gastroenterol | 2021 | 34908808 | PubTator, text mining | PubMed |
| Genetic epidemiology of autoinflammatory disease variants in Indian population from 1029 whole genomes. | J Genet Eng Biotechnol | 2021 | 34905135 | PubTator, text mining | PubMed |
| Differential Role of PD-1 Expressed by Various Immune and Tumor Cells in the Tumor Immune Microenvironment: Expression, Function, Therapeutic Efficacy, and Resistance to Cancer Immunotherapy. | Front Cell Dev Biol | 2021 | 34901012 | PubTator, text mining | PubMed |
| Colchicine Effectiveness and Safety in Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis. | Front Pediatr | 2021 | 34900867 | PubTator, text mining | PubMed |
| Reactive Oxygen Species: Do They Play a Role in Adaptive Immunity? | Front Immunol | 2021 | 34899706 | PubTator, text mining | PubMed |
| IL-6 and IL-10 gene polymorphisms and cirrhosis of liver risk from a comprehensive analysis. | BMC Endocr Disord | 2021 | 34886817 | PubTator, text mining | PubMed |
| Molecular Alterations Associated with Acquired Drug Resistance during Combined Treatment with Encorafenib and Binimetinib in Melanoma Cell Lines. | Cancers (Basel) | 2021 | 34885166 | PubTator, text mining | PubMed |
| Resistance to Targeted Agents Used to Treat Paediatric ALK-Positive ALCL. | Cancers (Basel) | 2021 | 34885113 | PubTator, text mining | PubMed |
| Do Extracellular RNAs Provide Insight into Uveal Melanoma Biology? | Cancers (Basel) | 2021 | 34885029 | PubTator, text mining | PubMed |
| Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity. | Immunity | 2021 | 34879221 | PubTator, text mining | PubMed |
| The Construction and Comprehensive Analysis of a ceRNA Immunoregulatory Network and Tissue-Infiltrating Immune Cells in Atrial Fibrillation. | Int J Gen Med | 2021 | 34876841 | PubTator, text mining | PubMed |
| IL-22 Binding Protein (IL-22BP) in the Regulation of IL-22 Biology. | Front Immunol | 2021 | 34868019 | PubTator, text mining | PubMed |
| Monogenic Adult-Onset Inborn Errors of Immunity. | Front Immunol | 2021 | 34867986 | PubTator, text mining | PubMed |
| High-Throughput RNA Sequencing Reveals the Effect of NB-UVB Phototherapy on Major Inflammatory Molecules of Lesional Psoriasis. | Psoriasis (Auckl) | 2021 | 34858799 | PubTator, text mining | PubMed |
| Tumor cell-derived IL-10 promotes cell-autonomous growth and immune escape in diffuse large B-cell lymphoma. | Oncoimmunology | 2021 | 34858727 | PubTator, text mining | PubMed |
| Interaction Between Commensal Bacteria, Immune Response and the Intestinal Barrier in Inflammatory Bowel Disease. | Front Immunol | 2021 | 34858414 | PubTator, text mining | PubMed |
| Comprehensive analysis of prognostic immune-related genes and drug sensitivity in cervical cancer. | Cancer Cell Int | 2021 | 34852825 | PubTator, text mining | PubMed |
| Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC. | J Hepatocell Carcinoma | 2021 | 34849372 | PubTator, text mining | PubMed |
| Challenging the Conventional Interpretation of HCMV Seronegativity. | Microorganisms | 2021 | 34835508 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3587/papers?page=48